Distortion product otoacoustic emission for the screening of cochlear damage in children treated with cisplatin

Laryngoscope

Volumn 121, Issue 5, 2011, Pages 1081-1084

  Al Noury, Khaled ^a,b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b NONE   (Saudi Arabia)

Author keywords

Cisplatin; otoacoustic emissions; ototoxicity

Indexed keywords

BLEOMYCIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE;

ADOLESCENT; ARTICLE; AUDIOGRAPHY; AUDIOMETRY; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CHILDHOOD INJURY; CLINICAL ARTICLE; COCHLEA INJURY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; EVOKED OTOACOUSTIC EMISSION; FEMALE; GERM CELL TUMOR; GLIOMA; HEARING; HEARING LOSS; HUMAN; INTERMETHOD COMPARISON; MALE; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; OSTEOSARCOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TERTIARY HEALTH CARE; TESTIS TUMOR;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CISPLATIN; COCHLEAR DISEASES; FEMALE; HUMANS; MALE; OTOACOUSTIC EMISSIONS, SPONTANEOUS; PROSPECTIVE STUDIES;

EID: 79955543866     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21740     Document Type: Article

References (20)

1. Schaefer SD, Post JD, Close LG, Wright CG,. Ototoxicity of low - and moderate-dose cisplatin. Cancer 1985; 56: 1934-1939.
2. Fausti SA, Henry JA, Schaffer HI, Olson DJ, Frey RH, Bagby GC Jr,. High-frequency monitoring for early detection of cisplatin ototoxicity. Arch Otolaryngol Head Neck Surg 1993; 119: 661-666. (Pubitemid 23161975)
3. Sockalingam R, Filippich L, Charles B, Murdoch B,. Cisplatin-induced ototoxicity and pharmacokinetics: preliminary findings in a dog model. Ann Otol Rhinol Laryngol 2002; 111: 745-750. (Pubitemid 34864256)
4. Forastiere AA, Gennis M, Orringer MB, Agha FP,. Cisplatin, vinblastine, and mitoguazone chemotherapy for epidermoid and adenocarcinoma of the esophagus. J Clin Oncol 1987; 5: 1143-1149. (Pubitemid 18045298)
5. Kopelman J, Budnick AS, Sessions RB, Kramer MB, Wong GY,. Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing. Laryngoscope 1988; 98: 858-864.
6. Kemp DT,. Stimulated acoustic emissions from within the human auditory system. J Acoust Soc Am 1978; 64: 1386-1391. (Pubitemid 9051752)
7. Kemp DT,. Otoacoustic emissions, travelling waves and cochlear mechanisms. Hear Res 1986; 22: 95-104. (Pubitemid 16068832)
8. Lim DJ,. Cochlear micromechanics in understanding otoacoustic emission. Scand Audiol Suppl 1986; 25: 17-25. (Pubitemid 17228926)
9. American Speech-Language-Hearing Association. (1994). Audiologic Management of Individuals Receiving Cochleotoxic Drug Therapy [Guidelines]. Available from:. Accessed march 4, 2011.
10. Chida E, Fukuda S, Satoh N, et al. Optimal stimulus level conditions for measurements of distortion product otoacoustic emissions. Auris Nasus Larynx 2001; 28 (Suppl): S19-S22.
11. Toral-Martinon R, Shkurovich-Bialik P, Collado-Corona MA, Mora-Magana I, Goldgrub-Listopad S, Shkurovich-Zaslavsky M,. Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment. Arch Med Res 2003; 34: 205-208. (Pubitemid 36870710)
12. Berg AL, Spitzer JB, Garvin JH Jr,. Ototoxic impact of cisplatin in pediatric oncology patients. Laryngoscope 1999; 109: 1806-1814. (Pubitemid 29533925)
13. Zorowka PG, Schmitt HJ, Gutjahr P,. Evoked otoacoustic emissions and pure tone threshold audiometry in patients receiving cisplatinum therapy. Int J Pediatr Otorhinolaryngol 1993; 25: 73-80. (Pubitemid 23051642)
14. Reavis KM, McMillan G, Austin D, et al. Distortion-product otoacoustic emission test performance for ototoxicity monitoring. Ear Hear 2011; 32: 61-74.
15. Fausti SA, Larson VD, Noffsinger D, Wilson RH, Phillips DS, Fowler CG,. High-frequency audiometric monitoring strategies for early detection of ototoxicity. Ear Hear 1994; 15: 232-239. (Pubitemid 24173826)
16. Simpson TH, Schwan SA, Rintelmann WF,. Audiometric test criteria in the detection of cisplatin ototoxicity. J Am Acad Audiol 1992; 3: 176-185.
17. Zorowka PG,. Otoacoustic emissions: a new method to diagnose hearing impairment in children. Eur J Pediatr 1993; 152: 626-634. (Pubitemid 23211144)
18. Bonfils P, Uziel A,. Clinical applications of evoked acoustic emissions: results in normally hearing and hearing-impaired subjects. Ann Otol Rhinol Laryngol 1989; 98: 326-331. (Pubitemid 19133135)
19. Allen GC, Tiu C, Koike K, Ritchey AK, Kurs-Lasky M, Wax MK,. Transient-evoked otoacoustic emissions in children after cisplatin chemotherapy. Otolaryngol Head Neck Surg 1998; 118: 584-588. (Pubitemid 28222198)
20. Jacob LC, Aguiar FP, Tomiasi AA, Tschoeke SN, Bitencourt RF,. Auditory monitoring in ototoxicity. Braz J Otorhinolaryngol 2006; 72: 836-844. (Pubitemid 46182724)